Cengild Medical Berhad (KLSE:CENGILD)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions MYR. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	208	262	329	328	-	-
Market Cap Growth	-16.39%	-20.25%	0.45%	-	-	-
Enterprise Value	154	188	255	331	-	-
Last Close Price	0.25	0.30	0.37	0.37	-	-
PE Ratio	20.16	23.68	24.76	34.88	-	-
Forward PE	-	23.00	23.00	24.24	-	-
PS Ratio	2.70	3.93	4.68	5.08	-	-
PB Ratio	1.86	2.36	3.10	3.52	-	-
P/TBV Ratio	1.86	2.36	3.10	3.52	-	-
P/FCF Ratio	-	-	27.92	21.98	-	-
P/OCF Ratio	6.93	20.28	23.65	21.37	-	-
PEG Ratio	-	0.64	0.64	0.67	-	-
EV/Sales Ratio	2.00	2.81	3.62	5.14	-	-
EV/EBITDA Ratio	8.59	12.64	15.59	22.72	-	-
EV/EBIT Ratio	13.36	15.25	17.60	28.61	-	-
EV/FCF Ratio	-8.35	-	21.60	22.21	-	-
Debt / Equity Ratio	0.32	0.07	0.14	0.17	1.76	2.96
Debt / EBITDA Ratio	2.04	0.50	0.85	1.01	1.25	2.47
Debt / FCF Ratio	-	-	1.27	1.09	1.92	2.72
Asset Turnover	0.50	0.51	0.56	0.78	1.36	0.84
Inventory Turnover	18.90	23.10	31.23	36.62	42.83	26.16
Quick Ratio	4.35	6.59	9.17	7.91	1.06	0.74
Current Ratio	4.44	6.73	9.32	8.04	1.16	0.81
Return on Equity (ROE)	9.34%	10.19%	13.35%	17.60%	84.90%	50.59%
Return on Assets (ROA)	4.65%	5.83%	7.19%	8.74%	19.43%	9.43%
Return on Capital (ROIC)	5.23%	6.41%	7.85%	9.83%	23.59%	11.23%
Return on Capital Employed (ROCE)	7.80%	10.50%	12.00%	10.70%	41.30%	20.70%
Earnings Yield	4.98%	4.22%	4.04%	2.87%	-	-
FCF Yield	-8.88%	-1.07%	3.58%	4.55%	-	-
Dividend Yield	4.80%	2.43%	1.98%	0.99%	-	-
Payout Ratio	77.94%	55.64%	45.60%	-	72.81%	-
Buyback Yield / Dilution	-0.13%	-1.00%	-27.94%	-7.56%	-4700.00%	-
Total Shareholder Return	4.77%	1.44%	-25.96%	-6.56%	-4700.00%	-

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.